Replies to post #213285 on Biotech Values

[drbio45]

Kite was probably going to charge 500 thousand a year for their drug

will Gilead be able to do that?

[lgonber]

I would bet on JUNO, as CELG bought shares at double price of what they are now, just approx two years ago and they have a patent dispute with KITE